首页> 外国专利> 13--1236--26--9--8 SUBSTITUTED 13-BISCYCLOHEXYLMETHYL-1236-TETRAHYDRO-26-DIOXO-9H-PURIN-8YLPHENYL DERIVATIVES THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF INFLAMMATORY CONDITIONS AND IMMUNE DISORDERS

13--1236--26--9--8 SUBSTITUTED 13-BISCYCLOHEXYLMETHYL-1236-TETRAHYDRO-26-DIOXO-9H-PURIN-8YLPHENYL DERIVATIVES THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF INFLAMMATORY CONDITIONS AND IMMUNE DISORDERS

机译:13--1236--26--9--8取代的13-双环己基甲基-1236-四氢-26-二恶英-9H-PURIN-8联苯衍生物的制备及其在治疗炎症和免疫疾病中的用途

摘要

A compound of formula (Ⅰ) or solvate.; (Ⅰ); Wherein, X is -O- or -NH-, Q is - of p, (-CH = CH-) p , (-C≡C-) p ( where p is 0 to 4 (-CH 2) an integer) and, R 1 is hydrogen or methyl, R 2 and R 3 is O or S independently, n is an integer from 1 to 50, R is hydrogen or methyl. A series of mixed esters and amides of this particular phenyl xanthine derivatives inhibits human umbilical vein endothelial cells (HUVEC) expression of adhesion molecules in the monolayer at a very low concentration, and thus suggesting that it can be used for the inflammatory diseases and immune or more of treatment.
机译:式(Ⅰ)化合物或溶剂化物。 (Ⅰ);其中,X是 p的-O-或-NH-,Q是-(-CH = CH-)p ,(-C≡C-)p(其中p是0到4(-CH 2)是整数),R 1 是氢或甲基,R 2 和R 3 独立地为O或S,n为1至50的整数,R为氢或甲基。这种特定的苯基黄嘌呤衍生物的一系列混合酯和酰胺以非常低的浓度抑制人脐静脉内皮细胞(HUVEC)在单层中的粘附分子表达,因此表明它可以用于炎症性疾病和免疫或更多的治疗。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号